- PR Newswire•4 days ago
ALBANY, N.Y., March 22, 2017 /PRNewswire/ -- AMRI (AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, has been recognized for its excellence as a contract manufacturing organization (CMO). AMRI has been honored as part of the Life Science Leader's 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability. "Competing with more than 80 contract manufacturers, AMRI is honored to be recognized by our customers from industry pharma and biopharma companies," said William S. Marth, president and CEO, AMRI.
- Motley Fool•16 days ago
Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.
- PR Newswire•23 days ago
ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global ...
AMRI : Summary for Albany Molecular Research, Inc. - Yahoo Finance
Albany Molecular Research, Inc. (AMRI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||13.03 - 13.41|
|52 Week Range||12.45 - 19.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-7.21|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|